Annual Report to the Nation on the Status of Cancer, 1975-2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control

被引:724
作者
Jemal, Ahmedin [1 ]
Thun, Michael J. [1 ]
Ries, Lynn A. G. [4 ]
Howe, Holly L. [5 ]
Weir, Hannah K. [2 ]
Center, Melissa M. [1 ]
Ward, Elizabeth [1 ]
Wu, Xiao-Cheng [5 ,6 ]
Eheman, Christie [2 ]
Anderson, Robert [3 ]
Ajani, Umed A. [2 ]
Kohler, Betsy [5 ,7 ]
Edwards, Brenda K. [4 ]
机构
[1] Amer Canc Soc, Epidemiol & Surveillance Res Dept, Atlanta, GA 30303 USA
[2] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Canc Prevent & Control, Atlanta, GA USA
[3] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Div Vital Stat, Hyattsville, MD 20782 USA
[4] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA
[5] N Amer Assoc Cent Canc Registries, Springfield, IL USA
[6] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA
[7] Canc Epidemiol Serv, New Jersey Dept Hlth & Senior Serv, Trenton, NJ USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2008年 / 100卷 / 23期
关键词
D O I
10.1093/jnci/djn389
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The American Cancer Society, the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) collaborate annually to provide updated information on cancer occurrence and trends in the United States. This year's report includes trends in lung cancer incidence and death rates, tobacco use, and tobacco control by state of residence. Information on invasive cancers was obtained from the NCI, CDC, and NAACCR and information on mortality from the CDC's National Center for Health Statistics. Annual percentage changes in the age-standardized incidence and death rates (2000 US population standard) for all cancers combined and for the top 15 cancers were estimated by joinpoint analysis of long-term (1975-2005) trends and by least squares linear regression of short-term (1996-2005) trends. All statistical tests were two-sided. Both incidence and death rates from all cancers combined decreased statistically significantly (P < .05) in men and women overall and in most racial and ethnic populations. These decreases were driven largely by declines in both incidence and death rates for the three most common cancers in men (lung, colorectum, and prostate) and for two of the three leading cancers in women (breast and colorectum), combined with a leveling off of lung cancer death rates in women. Although the national trend in female lung cancer death rates has stabilized since 2003, after increasing for several decades, there is prominent state and regional variation. Lung cancer incidence and/or death rates among women increased in 18 states, 16 of them in the South or Midwest, where, on average, the prevalence of smoking was higher and the annual percentage decrease in current smoking among adult women was lower than in the West and Northeast. California was the only state with decreasing lung cancer incidence and death rates in women. Although the decrease in overall cancer incidence and death rates is encouraging, large state and regional differences in lung cancer trends among women underscore the need to maintain and strengthen many state tobacco control programs.
引用
收藏
页码:1672 / 1694
页数:23
相关论文
共 113 条
  • [41] A clinical blueprint to accelerate the elimination of tobacco use
    Fiore, Michael C.
    Jaen, Carlos Roberto
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (17): : 2083 - 2085
  • [42] Fritz A, 2000, International classification of diseases for oncology, V3rd
  • [43] Lung cancer, smoke exposure, and sex
    Gazdar, Adi F.
    Thun, Michael J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) : 469 - 471
  • [44] Breast cancer incidence, 1980-2006: Combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status
    Glass, Andrew G.
    Lacey, James V., Jr.
    Carreon, Daniel
    Hoover, Robert N.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (15): : 1152 - 1161
  • [45] Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation -: A randomized controlled trial
    Gonzales, David
    Rennard, Stephen I.
    Nides, Mitchell
    Oncken, Cheryl
    Azoulay, Salomon
    Billing, Clare B.
    Watsky, Eric J.
    Gong, Jason
    Williams, Kathryn E.
    Reeves, Karen R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (01): : 47 - 55
  • [46] HARRIS JE, 1983, JNCI-J NATL CANCER I, V71, P473
  • [47] Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends
    Howe, HL
    Wingo, PA
    Thun, MJ
    Ries, LAG
    Rosenberg, HM
    Feigal, EG
    Edwards, BK
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (11) : 824 - 842
  • [48] HOWE HL, 2003, CANC US HISPANICS LA
  • [49] Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among US Hispanic/Latino populations
    Howe, Holly L.
    Wu, Xiaocheng
    Ries, Lynn A. G.
    Cokkinides, Vilma
    Ahmed, Faruque
    Jemal, Ahmedin
    Miller, Barry
    Williams, Melanie
    Ward, Elizabeth
    Wingo, Phyllis A.
    Ramirez, Amelie
    Edwards, Brenda K.
    [J]. CANCER, 2006, 107 (08) : 1711 - 1742
  • [50] Husten C G, 1997, Tob Control, V6, P175, DOI 10.1136/tc.6.3.175